Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Urigen Files Request for FDA Meeting
Yahoo/BusinessWire
Saturday, April 24, 2010 - 1:00pm
tags:
Painful Bladder Syndrome, Interstitial Cystitis, Urigen Pharmaceuticals, URG101
Advanced Cell Technology's Studies to Support Phase I Multicenter Trial of Patients with Stargardt's Macular Dystrophy Demonstrate Excellent Safety Profile
Yahoo/BusinessWire
Saturday, April 24, 2010 - 12:58pm
tags:
Advanced Cell Technologies, stem cells, Retinal Pigment Epithelium, macular dystrophy
Four Standard-Bearers For Stem Cell Therapies
Forbes
Friday, April 23, 2010 - 11:56am
tags:
stem cells, Geron, Cytori, Celgene, Athersys
Cadence to Re-file Application
Yahoo/Zacks.com
Friday, April 23, 2010 - 11:54am
tags:
Cadence Pharmaceuticals, Ofirmev, NDA, Bristol-Myers Squibb
Anika: A Hidden Biotech Buy
Seeking Alpha
Friday, April 23, 2010 - 11:52am
tags:
Anika, biotech
Novo's Victoza beats Merck's Januvia in company-funded study
Fierce Pharma
Friday, April 23, 2010 - 11:50am
tags:
Novo Nordisk, Victoza, Merck, diabetes, Januvia
EU approves Novartis' Diovan for pediatric use
Reuters
Friday, April 23, 2010 - 11:47am
tags:
Europe, Novartis, Diovan, pediatrics
Sun's generic Eloxatin sales to be stopped: Sanofi
Marketwatch
Friday, April 23, 2010 - 11:45am
tags:
Sun Pharma, Eloxatin, generics, Sanofi
Pfizer shareholders reject ban on stock options
Google/AP
Friday, April 23, 2010 - 11:29am
tags:
Pfizer, shareholders, stock options
Roche files new Herceptin use for US approval
Reuters
Friday, April 23, 2010 - 11:28am
tags:
Roche, Herceptin, stomach cancer
Dendreon Preview: Drama Could Culminate in the First Cancer Vaccine Approval
BNET Pharma
Friday, April 23, 2010 - 11:26am
tags:
Dendreon, vaccines, Provenge, prostate cancer
Gene Therapy Takes a Turn for the Better
Businessweek
Friday, April 23, 2010 - 11:25am
tags:
gene therapy, Genzyme, Roche/Genentech, Genetix
CSL Suspends Child's Flu Vaccine
WSJ Online
Friday, April 23, 2010 - 11:23am
tags:
CSL, Flu, Australia, vaccines
Pfizer ends trial of Sutent in liver cancer
Yahoo/AP
Friday, April 23, 2010 - 7:58am
tags:
Pfizer, clinical trials, liver cancer, Sutent, Nexavar, Bayer, ONYX Pharmaceuticals
Astellas Extends Offer Deadline for OSI a Second Time
Bloomberg
Friday, April 23, 2010 - 7:47am
tags:
Astellas, OSI Pharmaceuticals, M&A
Daily Malaria Drug Matches Twice-a-Day Novartis Pill
Bloomberg
Friday, April 23, 2010 - 7:46am
tags:
Novartis, malaria, Coartem, Shin Poong, South Korea
Forest Labs dumps $340M diabetes drug pact with Phenomix
Fierce Biotech
Friday, April 23, 2010 - 7:43am
tags:
Phenomix, diabetes, Forest Labs
No Drug Can Cure the Health-Care Reform Infection
Motley Fool
Thursday, April 22, 2010 - 8:12pm
tags:
Enbrel, Pfizer, healthcare reform, earnings, Neulasta, Amgen, Neupogen, Humira, Abbott Laboratories, Remicade, Merck, JNJ
FDA panel rejects abuse-resistant painkiller
Yahoo/AP
Thursday, April 22, 2010 - 8:10pm
tags:
FDA, advisory panels, abuse-resistant painkillers, Acura Pharmaceuticals, Acurox, King
Acurox Under Fire at FDA Panel
Minyanville
Thursday, April 22, 2010 - 4:22pm
tags:
Acurox, FDA, advisory panels, King, abuse-resistant painkillers

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.